A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity

This study has been completed.
Sponsor:
Collaborator:
Valeant Pharmaceuticals International, Inc.
Information provided by:
Thomas Jefferson University
ClinicalTrials.gov Identifier:
NCT00203268
First received: September 13, 2005
Last updated: January 22, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2005
  Estimated Primary Completion Date: No date given